Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2010 | 1 |
2012 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
EMBO Mol Med. 2022 Dec 7;14(12):e15200. doi: 10.15252/emmm.202115200. Epub 2022 Nov 7.
EMBO Mol Med. 2022.
PMID: 36341492
Free PMC article.
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Suske T, Sorger H, Manhart G, Ruge F, Prutsch N, Zimmerman MW, Eder T, Abdallah DI, Maurer B, Wagner C, Schönefeldt S, Spirk K, Pichler A, Pemovska T, Schweicker C, Pölöske D, Hubanic E, Jungherz D, Müller TA, Aung MMK, Orlova A, Pham HTT, Zimmel K, Krausgruber T, Bock C, Müller M, Dahlhoff M, Boersma A, Rülicke T, Fleck R, de Araujo ED, Gunning PT, Aittokallio T, Mustjoki S, Sanda T, Hartmann S, Grebien F, Hoermann G, Haferlach T, Staber PB, Neubauer HA, Look AT, Herling M, Moriggl R.
Suske T, et al. Among authors: fleck r.
J Clin Invest. 2024 Apr 15;134(8):e168536. doi: 10.1172/JCI168536.
J Clin Invest. 2024.
PMID: 38618957
Free PMC article.
Item in Clipboard
Trends in Personalized Therapies in Oncology: The (Venture) Capitalist's Perspective.
Fleck R, Bach D.
Fleck R, et al.
J Pers Med. 2012 Mar 7;2(1):15-34. doi: 10.3390/jpm2010015.
J Pers Med. 2012.
PMID: 25562700
Free PMC article.
Item in Clipboard
The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part II.
Wu JP, Fleck R, Brickwood J, Capolino A, Catron K, Chen Z, Cywin C, Emeigh J, Foerst M, Ginn J, Hrapchak M, Hickey E, Hao MH, Kashem M, Li J, Liu W, Morwick T, Nelson R, Marshall D, Martin L, Nemoto P, Potocki I, Liuzzi M, Peet GW, Scouten E, Stefany D, Turner M, Weldon S, Zimmitti C, Spero D, Kelly TA.
Wu JP, et al. Among authors: fleck r.
Bioorg Med Chem Lett. 2009 Oct 1;19(19):5547-51. doi: 10.1016/j.bmcl.2009.08.054. Epub 2009 Aug 15.
Bioorg Med Chem Lett. 2009.
PMID: 19716697
Item in Clipboard
Substituted pyrazoles as novel sEH antagonist: investigation of key binding interactions within the catalytic domain.
Lo HY, Man CC, Fleck RW, Farrow NA, Ingraham RH, Kukulka A, Proudfoot JR, Betageri R, Kirrane T, Patel U, Sharma R, Hoermann MA, Kabcenell A, Lombaert SD.
Lo HY, et al. Among authors: fleck rw.
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6379-83. doi: 10.1016/j.bmcl.2010.09.095. Epub 2010 Sep 19.
Bioorg Med Chem Lett. 2010.
PMID: 20934334
Item in Clipboard
2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocket.
Lo HY, Bentzien J, Fleck RW, Pullen SS, Khine HH, Woska JR Jr, Kugler SZ, Kashem MA, Takahashi H.
Lo HY, et al. Among authors: fleck rw.
Bioorg Med Chem Lett. 2008 Dec 1;18(23):6218-21. doi: 10.1016/j.bmcl.2008.09.098. Epub 2008 Oct 2.
Bioorg Med Chem Lett. 2008.
PMID: 18930400
Item in Clipboard
Cite
Cite